For individuals who have not made the sort of risk-averse decisions in their lives that lead to better jobs and wealth accumulation, making treatment decisions after a cancer diagnosis can be very difficult, said Amy Davidoff, PhD, MS, senior research scientist in public health at the Yale School of Public Health
For individuals who have not made the sort of risk-averse decisions in their lives that lead to better jobs and wealth accumulation, making treatment decisions after a cancer diagnosis can be very difficult, said Amy Davidoff, PhD, MS, senior research scientist in public health at the Yale School of Public Health
Transcript (slightly modified for readability)
How can providers help patients with cancer make treatment decisions?
People are making choices all throughout their lives. Some people are much more risk averse, they invest in their education, they have better jobs, they accumulate wealth and at the end of their life they are able to tap into those resources, they are able to understand therapeutic choices, they're able to use their resources to make choices that are best for them and their family. A lot of people though, have not made those kind of risk-averse choices over time and then all of a sudden they are faced with this decision—it's a very difficult one.
You have a lot of individuals, and I think this may be the root of a lot of disparities concerns: low-income individuals, oftentime minorities, have not had the opportunity to accumulate wealth throughout their lifetime. And so when it comes to end-of-life decision choose to not get therapy at all and you see that in the patterns of care that we observe and research.
And I think it's going to be a huge challenge as a society to not only correct those disparities in resources at the time a treatment choice is faced, but also think about ways to improve education and opportunities earlier on in life so we don't have these sort of disparities of position when you're faced with that end-of-life choice.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More